Avante (XX) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
14 May, 2026Opening remarks and agenda
Meeting held virtually with full participation and voting rights for registered shareholders and proxy holders.
Agenda included receipt of financial statements, appointment of auditors, election of directors, and approval of the stock option plan.
Shareholders encouraged to submit questions and vote throughout the meeting.
Board and executive committee updates
Five director nominees presented: Dan Argiros, Wade Burton, Robert Klopot, Emmanuel Mounouchos, and Bruce Bronfman.
No other director nominations or shareholder proposals received in accordance with bylaws.
All nominees confirmed eligible and elected by majority vote.
Financial performance review
Audited consolidated financial statements for fiscal years ending March 31, 2025 and 2024, and unaudited interim statements for June 30, 2025 and 2024, presented and received.
No questions raised by shareholders regarding the financial statements.
Latest events from Avante
- Management nominees elected, shareholder proposals defeated, and strategic growth plans outlined.XX
AGM 202414 May 2026 - Advanced security technology and acquisitions drive strong growth and global expansion.XX
Investor presentation22 Apr 2026 - AI-powered security solutions and recurring revenue drive robust growth and global expansion.XX
Investor presentation4 Mar 2026 - Q3 2026 delivered strong revenue and profit growth, with robust recurring revenues and segment gains.XX
Q3 20263 Mar 2026 - 46% revenue growth and recurring revenue gains highlight robust Q1 performance.XX
Q1 202523 Jan 2026 - Q2 revenue up 52% year-over-year, with strong recurring growth and new AI security launches.XX
Q2 202512 Jan 2026 - Record Q3 revenue and EBITDA growth fueled by recurring revenue and innovation, with strong outlook.XX
Q3 202526 Dec 2025 - Q2 2026 saw 10% revenue growth, 73% higher EBITDA, and a strong debt-free position.XX
Q2 20261 Dec 2025 - Revenue up 11%, recurring revenue up 25%, NSSG up 126%, and net income positive.XX
Q1 202623 Nov 2025